Return to previous page|
On 1 April 2013 the National Institute for Biological Standards
and Control (NIBSC), currently part of the Health Protection Agency
(HPA), will officially become a new ‘centre’ of the Medicines and
Healthcare products Regulatory Agency (MHRA) alongside the Clinical
Practice Research Datalink (CPRD).
MHRA and NIBSC already work closely together and have common
interests in managing risks associated with biological medicines,
facilitating development of new medicines safely and effectively,
and maintaining UK expertise and ability to contribute to assuring
the quality and safety of medicines in Europe and beyond.
The developments will create a new organisation that is a world
leader in supporting science and research and the regulation of
medicines and medical devices, and will strengthen the support
provided to the UK’s medicine’s industry.
See our questions and answers section
below for more on the developments and if you have any further
questions or comments on the merger you can contact us on
0203 080 6000.